Sichuan Hebang Biotechnology (603077.SH) issued a profit warning, expecting a 96.88% to 97.66% year-on-year decline in net profit for the fiscal year 2024.
Habio (603077.SH) announces a decrease in performance forecast for the year 2024, expecting a decrease in net profit...
Sichuan Hebang Biotechnology (603077.SH) announced a forecasted decrease in performance for the year 2024, estimating a net profit attributable to shareholders of the listed company of 30 to 40 million yuan, a year-on-year decrease of 96.88% to 97.66%.
Related Articles
US Stock Market Move | Some cryptocurrency-related stocks rallied, with Circle (CRCL.US) rising nearly 7%.
CoreWeave (CRWV.US) shares plunged nearly 15% at one point! Bond yields approaching 15% spark financing concerns; Bernstein warns that the high-debt growth model is unsustainable.
A-share Evening Highlights | Flooding the screens! A-share companies are conducting buybacks and increasing holdings, and the wave of positive earnings pre-announcements continues. What signal does this send?
US Stock Market Move | Some cryptocurrency-related stocks rallied, with Circle (CRCL.US) rising nearly 7%.
CoreWeave (CRWV.US) shares plunged nearly 15% at one point! Bond yields approaching 15% spark financing concerns; Bernstein warns that the high-debt growth model is unsustainable.
A-share Evening Highlights | Flooding the screens! A-share companies are conducting buybacks and increasing holdings, and the wave of positive earnings pre-announcements continues. What signal does this send?
